Liminatus Pharma Launches $500M BNB-Focused Digital Asset Fund Through New Subsidiary
Liminatus Pharma has established American BNB Strategy, a new subsidiary dedicated to managing a $500 million digital asset fund concentrated on BNB tokens. This strategic move marks the biotechnology firm’s formal entry into the cryptocurrency sector while maintaining its core… Read More »Liminatus Pharma Launches $500M BNB-Focused Digital Asset Fund Through New Subsidiary